Callan Capital, LLC Cidara Therapeutics, Inc. Transaction History

Callan Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Oct 22, 2024	BUY	$0.64 - $0.92 $60,908 - $87,555	95,169 New	95,169 $87,000
Q1 2024 May 03, 2024	SELL	$0.64 - $0.92 $5,307 - $7,629	-8,293 Reduced 8.02%	95,169 $87,000
Q1 2023 May 08, 2023	BUY	$0.75 - $1.98 $37,500 - $99,000	50,000 Added 18.28%	323,554 $410,000
Q4 2022 Jun 13, 2023	SELL	$0.48 - $13.08 $105,644 - $2.88 Million	-220,092 Reduced 68.02%	103,462 $78,000
Q4 2022 Feb 13, 2023	BUY	$0.48 - $13.08 $131,305 - $3.58 Million	273,554 New	273,554 $207,000

Ticker CDTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,075,696
Market Cap $1.43B
Description
Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifu...

Get notified when there are updates to the investment portfolio of Callan Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Callan Capital, LLC with notifications on news.